Your session is about to expire
← Back to Search
Cryoablation for Rib Fracture Pain Control
Study Summary
This trial is studying a long-term pain control method for elderly patients with rib fractures. The goal is to help them heal without complications and return to their normal level of function.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Only certain ribs (1, 2, 10, 11, 12) being broken will exclude you from participating.My rib fracture is close to my spine.Your Glasgow Coma Scale (GCS) score is less than 13, which means you may have severe brain injury or impairment.I am over 65 and have a recent rib fracture.I am undergoing spinal stabilization surgery.I experience significant pain when taking a deep breath.The doctor in charge may decide not to perform cryoablation for reasons that they think are not suitable for you.
- Group 1: Image-guided percutaneous ICN (pICN): Group A
- Group 2: Standard-of Care : Group B
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants may enroll in this clinical trial?
"Confirmed. The information posted on the clinicaltrials.gov website shows that this research program is actively seeking participants, which began recruitment in June 2021 and was last modified in October 2022. 110 individuals are needed to join from a single medical site."
What objectives are hoped to be achieved by this clinical experiment?
"This medical trial, which will be closely monitored for a duration of 12 months, has Length of hospital stay as its primary outcome. Secondary goals involve 30-day rib-specific readmission rate recorded via chart review after discharge, McGill Pain Questionnaire (MPQ) and Pain Rating Index (PRI) Scale Score administered by study/ clinical staff during patient discharge; in addition to the number of participants needing ICU admission being observed."
Is recruitment for this investigation still open?
"Affirmative. Clinicaltrials.gov lists the trial as currently in progress with a first posting on June 1st 2021 and most recent edit on October 19th 2022. The study requires 110 patients from one site for participation."
Share this study with friends
Copy Link
Messenger